Oncolytics Biotech Inc. (ONCY)
NASDAQ: ONCY · Real-Time Price · USD
0.5270
-0.0230 (-4.18%)
At close: Apr 1, 2025, 4:00 PM
0.5461
+0.0191 (3.62%)
After-hours: Apr 1, 2025, 4:46 PM EDT

Oncolytics Biotech Income Statement

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Selling, General & Admin
13.3416.0811.4913.3212.51
Upgrade
Research & Development
21.6517.7115.4312.9212.95
Upgrade
Operating Expenses
34.9833.7926.9226.2425.46
Upgrade
Operating Income
-34.98-33.79-26.92-26.24-25.46
Upgrade
Interest & Investment Income
1.21.330.530.10.12
Upgrade
Currency Exchange Gain (Loss)
0.96-0.481.67-0.14-0.66
Upgrade
Other Non Operating Income (Expenses)
1.245.29-0.020.023.49
Upgrade
EBT Excluding Unusual Items
-31.58-27.66-24.75-26.26-22.51
Upgrade
Pretax Income
-31.58-27.66-24.75-26.26-22.51
Upgrade
Income Tax Expense
0.130.10.080.05-
Upgrade
Net Income
-31.71-27.75-24.84-26.3-22.51
Upgrade
Net Income to Common
-31.71-27.75-24.84-26.3-22.51
Upgrade
Shares Outstanding (Basic)
7668585440
Upgrade
Shares Outstanding (Diluted)
7668585440
Upgrade
Shares Change (YoY)
13.10%16.53%8.44%32.66%82.22%
Upgrade
EPS (Basic)
-0.41-0.41-0.43-0.49-0.56
Upgrade
EPS (Diluted)
-0.41-0.41-0.43-0.49-0.56
Upgrade
Free Cash Flow
-27.21-28.46-23.41-22.72-22.1
Upgrade
Free Cash Flow Per Share
-0.36-0.42-0.40-0.42-0.55
Upgrade
EBITDA
-34.88-33.71-26.83-26.11-25.37
Upgrade
D&A For EBITDA
0.10.080.090.130.09
Upgrade
EBIT
-34.98-33.79-26.92-26.24-25.46
Upgrade
Updated Mar 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q